• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

备用抗生素鼓励旅行者腹泻不合理使用抗生素:一项前瞻性研究。

Stand-by antibiotics encourage unwarranted use of antibiotics for travelers' diarrhea: A prospective study.

机构信息

Department of Bacteriology and Immunology, University of Helsinki, P.O. Box 21, FI-00014, Finland; Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, P.O. Box 348, FI-00029, Finland.

Inflammation Center, Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, P.O. Box 348, FI-00029, Finland.

出版信息

Travel Med Infect Dis. 2019 Jan-Feb;27:64-71. doi: 10.1016/j.tmaid.2018.06.007. Epub 2018 Jun 9.

DOI:10.1016/j.tmaid.2018.06.007
PMID:29894796
Abstract

BACKGROUND

As antibiotics predispose travelers to acquiring multidrug-resistant intestinal bacteria, they should no longer be considered a mainstay for treating travelers' diarrhea. It has been claimed that stand-by antibiotics are justified as a means to avoid visits to local healthcare providers which often lead to polypharmacy.

METHOD

We revisited the traveler data of 316 prospectively recruited volunteers with travelers' diarrhea by retrieving from questionnaires and health diaries information on antibiotic use, stand-by antibiotic carriage, and visits with local healthcare. Multivariable analysis was applied to identify factors associated with antibiotic use.

RESULTS

Among our 316 volunteers with travelers' diarrhea, however, carrying stand-by antibiotics seemed not to reduce the rate of healthcare-seeking; on the contrary, antibiotic use was more frequent among stand-by antibiotic carriers (34%) than non-carriers (11%). Antibiotics were equally taken for severe and incapacitating travelers' diarrhea, but compared to non-carriers, stand-by antibiotic carriers resorted to medication also for mild/moderate (38% vs. 4%) and non-incapacitating disease (29% vs. 5%). Antibiotic use was associated with stand-by antibiotic carriage (OR 7.2; 95%CI 2.8-18.8), vomiting (OR 3.5; 95%CI 1.3-9.5), incapacitating diarrhea (OR 3.6; 95%CI 1.3-9.8), age (OR 1.03; 95%CI 1.00-1.05), and healthcare visit for diarrhea (OR 465.3; 95%CI 22.5-9633.6).

CONCLUSIONS

Carriage of stand-by antibiotics encouraged less cautious use of antibiotics. Recommendations involving prescription of antibiotics for all travelers require urgent revision.

摘要

背景

由于抗生素会使旅行者更容易感染多药耐药性肠道细菌,因此它们不应再被视为治疗旅行者腹泻的主要药物。有人声称,备用抗生素是合理的,可以避免前往当地医疗机构就诊,因为这通常会导致多种药物联合使用。

方法

我们通过检索问卷和健康日记中关于抗生素使用、备用抗生素携带和当地医疗保健就诊的信息,重新分析了 316 名前瞻性招募的旅行者腹泻志愿者的数据。采用多变量分析来确定与抗生素使用相关的因素。

结果

然而,在我们的 316 名患有旅行者腹泻的志愿者中,携带备用抗生素似乎并没有降低寻求医疗保健的比率;相反,备用抗生素携带者(34%)比非携带者(11%)更频繁地使用抗生素。抗生素同样用于严重和使人丧失能力的旅行者腹泻,但与非携带者相比,备用抗生素携带者也会因轻度/中度(38%比 4%)和非使人丧失能力的疾病(29%比 5%)而使用药物。抗生素的使用与备用抗生素携带(OR 7.2;95%CI 2.8-18.8)、呕吐(OR 3.5;95%CI 1.3-9.5)、使人丧失能力的腹泻(OR 3.6;95%CI 1.3-9.8)、年龄(OR 1.03;95%CI 1.00-1.05)和因腹泻就诊(OR 465.3;95%CI 22.5-9633.6)有关。

结论

携带备用抗生素鼓励更不谨慎地使用抗生素。需要紧急修订涉及为所有旅行者开具抗生素处方的建议。

相似文献

1
Stand-by antibiotics encourage unwarranted use of antibiotics for travelers' diarrhea: A prospective study.备用抗生素鼓励旅行者腹泻不合理使用抗生素:一项前瞻性研究。
Travel Med Infect Dis. 2019 Jan-Feb;27:64-71. doi: 10.1016/j.tmaid.2018.06.007. Epub 2018 Jun 9.
2
Travelers' health problems and behavior: prospective study with post-travel follow-up.旅行者的健康问题与行为:旅行后随访的前瞻性研究
BMC Infect Dis. 2016 Jul 13;16:328. doi: 10.1186/s12879-016-1682-0.
3
Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.抗菌药物会增加旅行者被产超广谱β-内酰胺酶肠杆菌科细菌定植的风险。
Clin Infect Dis. 2015 Mar 15;60(6):837-46. doi: 10.1093/cid/ciu957. Epub 2015 Jan 21.
4
Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries.在一个大型前瞻性国防部受益人群队列中旅行者腹泻的流行病学及自我治疗情况
J Travel Med. 2015 May-Jun;22(3):152-60. doi: 10.1111/jtm.12179. Epub 2014 Dec 7.
5
[Travelers' diarrhea: resistance to antibiotics].[旅行者腹泻:对抗生素的耐药性]
Rev Med Suisse. 2006 May 10;2(65):1224-6, 1228, 1230 passim.
6
Inconvenience due to travelers' diarrhea: a prospective follow-up study.因旅行者腹泻导致的不便:一项前瞻性随访研究。
BMC Infect Dis. 2011 Nov 20;11:322. doi: 10.1186/1471-2334-11-322.
7
Travelers' preferences for the treatment and prevention of acute diarrhea.旅行者对急性腹泻治疗和预防的偏好。
J Travel Med. 2009 May-Jun;16(3):172-8. doi: 10.1111/j.1708-8305.2009.00317.x. Epub 2009 May 5.
8
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.一项关于利福昔明预防旅行者腹泻的随机、双盲、安慰剂对照试验。
Ann Intern Med. 2005 May 17;142(10):805-12. doi: 10.7326/0003-4819-142-10-200505170-00005.
9
Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers.波士顿地区国际旅行者中的旅行者腹泻及其他胃肠道症状
Am J Trop Med Hyg. 2017 Jun;96(6):1388-1393. doi: 10.4269/ajtmh.16-0447.
10
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers' Diarrhea.洛哌丁胺与抗菌药物联用治疗旅行者腹泻会增加产超广谱β-内酰胺酶细菌的感染风险。
Emerg Infect Dis. 2016 Jan;22(1):117-20. doi: 10.3201/eid2201.151272.

引用本文的文献

1
Biopsychosocial analysis of antibiotic use for the prevention or management of COVID-19 infections: A scoping review.生物心理社会因素分析在预防或治疗 COVID-19 感染中抗生素的使用:范围综述。
Res Social Adm Pharm. 2023 Apr;19(4):573-581. doi: 10.1016/j.sapharm.2022.11.011. Epub 2022 Dec 2.
2
International Travel as a Risk Factor for Carriage of Extended-Spectrum β-Lactamase-Producing in a Large Sample of European Individuals-The AWARE Study.国际旅行是欧洲人群携带产超广谱β-内酰胺酶的风险因素:AWARE 研究。
Int J Environ Res Public Health. 2022 Apr 14;19(8):4758. doi: 10.3390/ijerph19084758.
3
Multidrug-Resistant Lineage of Enterotoxigenic ST182 With Serotype O169:H41 in Airline Waste.
航空公司废弃物中具有O169:H41血清型的产肠毒素性ST182多重耐药谱系
Front Microbiol. 2021 Sep 7;12:731050. doi: 10.3389/fmicb.2021.731050. eCollection 2021.
4
Travel-Related Risk Behaviors and Antibiotic Use Among Older Travelers.老年旅行者中与旅行相关的风险行为及抗生素使用情况
Open Forum Infect Dis. 2021 Jul 28;8(8):ofab395. doi: 10.1093/ofid/ofab395. eCollection 2021 Aug.
5
Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli-prospective traveller study with literature review.产超广谱β-内酰胺酶的腹泻型大肠埃希菌——前瞻性旅行者研究及文献复习
J Travel Med. 2022 Jan 17;29(1). doi: 10.1093/jtm/taab042.
6
Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28-29th November 2018.会议报告:世界卫生组织关于建模全球五岁以下儿童肠道病原体死亡率和病因估计的研讨会。2018 年 11 月 28-29 日,开普敦。
Vaccine. 2020 Jun 26;38(31):4792-4800. doi: 10.1016/j.vaccine.2020.01.054. Epub 2020 Apr 3.
7
Quinolone nonsusceptibility among enteric pathogens isolated from international travelers - Foodborne Diseases Active Surveillance Network (FoodNet) and National Antimicrobial Monitoring System (NARMS), 10 United States sites, 2004 - 2014.肠病原体对喹诺酮类药物的耐药性-食源性疾病主动监测网络(FoodNet)和国家抗菌药物监测系统(NARMS),10 个美国地点,2004-2014 年。
PLoS One. 2019 Dec 4;14(12):e0225800. doi: 10.1371/journal.pone.0225800. eCollection 2019.
8
A Review of Guidelines/Guidance from Various Countries Around the World for the Prevention and Management of Travellers' Diarrhoea: A Pharmacist's Perspective.从药剂师角度审视世界各国关于旅行者腹泻预防与管理的指南/指导意见
Pharmacy (Basel). 2019 Aug 4;7(3):107. doi: 10.3390/pharmacy7030107.